Sep 18, 2020

Diabetes Management

Information about Medtronic insulin pump therapy, continuous glucose monitoring and therapy management software.

The following media kits are made available to provide reporters with background information on the range of Medtronic therapies and the conditions they treat.

 
Jun 21, 2018
Medtronic Receives FDA Approval of New Pediatric Indication for the MiniMed(TM) 670G Hybrid Closed Loop System in Children Ages 7-13

(GLOBE NEWSWIRE via COMTEX) --DUBLIN- June 21, 2018 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced that the U.S. Food and Drug Administration (FDA) has...
 
Mar 12, 2018
Medtronic Receives FDA Approval for Guardian Connect Continuous Glucose Monitoring (CGM) System for People Living with Diabetes
'Smart' CGM System Provides Predictive Alerts for Dangerous Sensor Glucose Levels; Exclusive Access to Sugar.IQ Assistant with Watson Offers More Proactive Diabetes Management

DUBLIN - March 12, 2018 - Medtronic plc (NYSE:MDT), the global leader in medical technology, services and solutions, today announced it received U.S. Food and Drug Administration (FDA) approval...
 
Sep 28, 2016
Medtronic Receives FDA Approval for World's First Hybrid Closed Loop System for People with Type 1 Diabetes
The MiniMed® 670G System Features the Company's Most Advanced SmartGuard(TM) Algorithm To-Date

DUBLIN - Sept. 28, 2016 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it has received U.S. Food and Drug Administration (FDA) approval of its MiniMed® 670G...
 
Aug 11, 2016
Medtronic Announces U.S. Launch of the MiniMed® 630G System with New User-Friendly Insulin Pump Design and SmartGuard(TM) Technology

DUBLIN - August 11, 2016 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced the U.S. commercial launch of its MiniMed 630G system with SmartGuard technology FDA...